0082N0 — Kanaph Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩599bn
- KR₩590bn
- KR₩6bn
Annual cashflow statement for Kanaph Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | -12,586 | -28,271 | -35,560 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | 2,501 | 24,117 | 31,608 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -7,467 | 403 | -81.2 | -4,143 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -7,467 | -8,817 | -3,230 | -7,167 |
| Capital Expenditures | -162 | -1,003 | -70.1 | -77.2 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 7,000 | -9,495 | 1,008 | -138 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 6,838 | -10,498 | 937 | -215 |
| Financing Cash Flow Items | — | — | -21.2 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 3,889 | 22,791 | 3,332 | -213 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 3,260 | 3,476 | 1,040 | -7,595 |